How aldosterone affects blood flow in small brain vessels

Aldosterone-Vascular Signaling on Cerebral Small Vessel Function

NIH-funded research University of Vermont & St Agric College · NIH-11029004

This study is looking at how a hormone called aldosterone affects tiny blood vessels in the brain, which are important for keeping our thinking sharp, and it aims to find out if too much of this hormone could lead to problems like dementia, with hopes of discovering new ways to help people with cognitive issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Vermont & St Agric College NIH-funded
Lab location1 site (Burlington, United States)
Project IDNIH-11029004 on NIH RePORTER

What this research studies

This research investigates the role of aldosterone, a hormone, in the function of small blood vessels in the brain, which are crucial for maintaining cognitive health. The study focuses on understanding how excess aldosterone can lead to dysfunction in these vessels, potentially contributing to conditions like dementia. By using specialized mouse models, researchers will explore the mechanisms by which aldosterone affects blood flow and nutrient delivery to brain cells. The findings could provide insights into new treatment strategies for vascular cognitive impairment.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals experiencing cognitive decline or those at risk for vascular cognitive impairment due to conditions like high blood pressure or hormonal imbalances.

Not a fit: Patients with cognitive impairment not related to vascular issues or those with other unrelated neurological conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that improve blood flow in the brain and help prevent or treat dementia.

How similar studies have performed: Previous research has shown promising results in understanding the vascular contributions to cognitive impairment, suggesting that this approach could yield valuable insights.

Where this research is happening

Burlington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.